Zimmer Biomet Valuation
| ZIM Stock | EUR 101.45 0.10 0.1% |
At this time, the company appears to be fairly valued. Zimmer Biomet Holdings maintains a prevalent Real Value of €100.4 per share. The last-minute price of the company is €101.45. Our model calculates the value of Zimmer Biomet Holdings from examining the company fundamentals such as Current Valuation of 29.79 B, profit margin of 0.03 %, and Return On Asset of 0.0371 as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Zimmer Biomet's price fluctuation is very steady at this time. Calculation of the real value of Zimmer Biomet Holdings is based on 3 months time horizon. Increasing Zimmer Biomet's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Zimmer stock is determined by what a typical buyer is willing to pay for full or partial control of Zimmer Biomet Holdings. Since Zimmer Biomet is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zimmer Stock. However, Zimmer Biomet's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 101.45 | Real 100.4 | Hype 101.45 | Naive 101.86 |
The real value of Zimmer Stock, also known as its intrinsic value, is the underlying worth of Zimmer Biomet Holdings Company, which is reflected in its stock price. It is based on Zimmer Biomet's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zimmer Biomet's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Zimmer Biomet Holdings helps investors to forecast how Zimmer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zimmer Biomet more accurately as focusing exclusively on Zimmer Biomet's fundamentals will not take into account other important factors: Zimmer Biomet Total Value Analysis
Zimmer Biomet Holdings is at this time estimated to have takeover price of 29.79 B with market capitalization of 24.63 B, debt of 5.32 B, and cash on hands of 403.1 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Zimmer Biomet fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.79 B | 24.63 B | 5.32 B | 403.1 M |
Zimmer Biomet Investor Information
About 91.0% of the company outstanding shares are owned by institutional investors. The book value of Zimmer Biomet was at this time reported as 57.51. The company has Price/Earnings To Growth (PEG) ratio of 1.06. Zimmer Biomet Holdings last dividend was issued on the 23rd of December 2022. Based on the key indicators related to Zimmer Biomet's liquidity, profitability, solvency, and operating efficiency, Zimmer Biomet Holdings is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Zimmer Biomet Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Zimmer Biomet has an asset utilization ratio of 32.94 percent. This implies that the Company is making €0.33 for each dollar of assets. An increasing asset utilization means that Zimmer Biomet Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Zimmer Biomet Ownership Allocation
Zimmer Biomet Holdings retains a total of 210.06 Million outstanding shares. The majority of Zimmer Biomet outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zimmer Biomet Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zimmer Biomet Holdings. Please pay attention to any change in the institutional holdings of Zimmer Biomet Holdings as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Zimmer Biomet Profitability Analysis
The company reported the revenue of 6.94 B. Net Income was 231.4 M with profit before overhead, payroll, taxes, and interest of 4.92 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Zimmer Biomet's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Zimmer Biomet and how it compares across the competition.
About Zimmer Biomet Valuation
The stock valuation mechanism determines Zimmer Biomet's current worth on a weekly basis. Our valuation model uses a comparative analysis of Zimmer Biomet. We calculate exposure to Zimmer Biomet's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zimmer Biomet's related companies.Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. ZIMMER BIOMET operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 19000 people.
8 Steps to conduct Zimmer Biomet's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Zimmer Biomet's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Zimmer Biomet's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Zimmer Biomet's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Zimmer Biomet's revenue streams: Identify Zimmer Biomet's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Zimmer Biomet's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Zimmer Biomet's growth potential: Evaluate Zimmer Biomet's management, business model, and growth potential.
- Determine Zimmer Biomet's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Zimmer Biomet's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |